Yawara Niijima

716 total citations
9 papers, 85 citations indexed

About

Yawara Niijima is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Yawara Niijima has authored 9 papers receiving a total of 85 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Endocrinology, Diabetes and Metabolism, 4 papers in Cardiology and Cardiovascular Medicine and 2 papers in Surgery. Recurrent topics in Yawara Niijima's work include Diabetes Treatment and Management (3 papers), Blood Pressure and Hypertension Studies (3 papers) and Cardiovascular Health and Disease Prevention (2 papers). Yawara Niijima is often cited by papers focused on Diabetes Treatment and Management (3 papers), Blood Pressure and Hypertension Studies (3 papers) and Cardiovascular Health and Disease Prevention (2 papers). Yawara Niijima collaborates with scholars based in Japan and United States. Yawara Niijima's co-authors include Masanobu Yamada, Sho Okada, Tetsu Ando, Kanae Ono, Kihachi Ohshima, Hiroyuki Shimizu, Tsugumichi Saito, Eijiro Yamada, Takafumi Tsuchiya and Masataka Mori and has published in prestigious journals such as Diabetic Medicine, Diabetes & Metabolic Syndrome Clinical Research & Reviews and Journal of Clinical Hypertension.

In The Last Decade

Yawara Niijima

8 papers receiving 82 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yawara Niijima Japan	4	54	44	19	17	8	9	85
O. Dupuy France	6	35 0.6×	44 1.0×	34 1.8×	14 0.8×	11 1.4×	23	104
Bahar Darouei Iran	6	32 0.6×	27 0.6×	20 1.1×	8 0.5×	12 1.5×	20	85
Andreana Foresta Italy	6	64 1.2×	37 0.8×	26 1.4×	15 0.9×	8 1.0×	10	105
Shaukat Sadikot Belgium	6	43 0.8×	19 0.4×	23 1.2×	29 1.7×	11 1.4×	6	97
Cailiang Yao China	6	34 0.6×	26 0.6×	18 0.9×	18 1.1×	9 1.1×	11	71
Soroush Masrouri Iran	6	21 0.4×	19 0.4×	12 0.6×	27 1.6×	9 1.1×	27	92
Jing Hong China	5	33 0.6×	22 0.5×	9 0.5×	9 0.5×	9 1.1×	18	77
Siyao He China	7	50 0.9×	18 0.4×	11 0.6×	29 1.7×	16 2.0×	20	94
Isabel Palma Portugal	4	41 0.8×	22 0.5×	43 2.3×	13 0.8×	14 1.8×	16	89
B. Fraiture Germany	4	19 0.4×	37 0.8×	14 0.7×	5 0.3×	5 0.6×	6	72

Countries citing papers authored by Yawara Niijima

Since Specialization

Citations

This map shows the geographic impact of Yawara Niijima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yawara Niijima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yawara Niijima more than expected).

Fields of papers citing papers by Yawara Niijima

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yawara Niijima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yawara Niijima. The network helps show where Yawara Niijima may publish in the future.

Co-authorship network of co-authors of Yawara Niijima

This figure shows the co-authorship network connecting the top 25 collaborators of Yawara Niijima. A scholar is included among the top collaborators of Yawara Niijima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yawara Niijima. Yawara Niijima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Okada, Shuichi, Kazuya Okada, Junichi Okada, et al.. (2024). Dipeptidyl peptidase-4 inhibitors may lower body temperature: A case-control study. Diabetes & Metabolic Syndrome Clinical Research & Reviews. 18(10). 103142–103142.

Osaki, Aya, Yoko Shimoda, Junichi Okada, et al.. (2019). Lower Renal Threshold for Glucose Reabsorption in Type 1 Diabetes Mellitus (T1DM) May Explain the Smaller Contribution of SGLT2 Inhibitors to the Improvement of Plasma Glucose Control Compared with T2DM. Diabetes Therapy. 10(4). 1531–1534. 2 indexed citations

Shimoda, Yoko, Eijiro Yamada, Tsugumichi Saito, et al.. (2018). As-required administration of sodium glucose co-transporter-2 inhibitors: three case studies. Drugs & Therapy Perspectives. 34(5). 231–233. 1 indexed citations

Yamada, Eijiro, Tsugumichi Saito, Yawara Niijima, Shuichi Okada, & Masanobu Yamada. (2017). Sodium glucose co-transporter 2 inhibitors successfully attenuated seasonal change of glycated haemoglobin A1c. Clinical Medicine. 17(4). 377–378. 2 indexed citations

Shimoda, Yoko, Tsugumichi Saito, Eijiro Yamada, et al.. (2016). Subcutaneous abdominal adipose tissue is associated with an index of insulin sensitivity/resistance. Adipocyte. 5(4). 375–377. 3 indexed citations

Osaki, Aya, Shuichi Okada, Tsugumichi Saito, et al.. (2016). Renal threshold for glucose reabsorption predicts diabetes improvement by sodium‐glucose cotransporter 2 inhibitor therapy. Journal of Diabetes Investigation. 7(5). 751–754. 18 indexed citations

Kario, Kazuomi, Jin Nariyama, Shin‐ichi Ando, et al.. (2013). Effect of a Novel Calcium Channel Blocker on Abnormal Nocturnal Blood Pressure in Hypertensive Patients. Journal of Clinical Hypertension. 15(7). 465–472. 15 indexed citations

Muranaka, Yoshinori, Tetsu Ando, Sho Okada, et al.. (2012). Elevated 1‐h plasma glucose following 75‐g oral glucose load is a predictor of arterial stiffness in subjects with normal glucose tolerance. Diabetic Medicine. 29(12). e457–60. 13 indexed citations

Ando, Tetsu, Sho Okada, Yawara Niijima, et al.. (2010). Impaired glucose tolerance, but not impaired fasting glucose, is a risk factor for early‐stage atherosclerosis. Diabetic Medicine. 27(12). 1430–1435. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact